Vimarsana
Biggest News Aggregation in the World

Headache Impact News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Headache Impact. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Headache Impact Today - Breaking & Trending Today

Fatigue, Depression More Common in Patients with Chronic Migraine - Vimarsana News

Fatigue, Depression More Common in Patients with Chronic Migraine

Fatigue was positively correlated with the frequency, duration, severity, and chronicity of migraine episodes, as well as excessive daytime sleepiness.

Fremanezumab May Prevent Migraines in Patients With History of Treatment Failure - Vimarsana News

Fremanezumab May Prevent Migraines in Patients With History of Treatment Failure

Fremanezumab demonstrated safety and efficacy in monthly migraine and headache reduction among patients with difficult-to-treat migraines.

Long-term benefits of Vyepti® confirmed by new data presented at the annual meeting of the American Headache Society - Vimarsana News

Long-term benefits of Vyepti® confirmed by new data presented at the annual meeting of the American Headache Society

Long-term benefits of Vyepti® confirmed by new data presented at the annual meeting of the American Headache SocietyAn extension phase of the DELIVER study with Vyepti® (eptinezumab) demonstrated long-lasting migraine preventive effects with treatment for up to 18 months, reducing both frequency and severity...

Self-Management Program for Chronic Migraine Does Not Improve Quality of Life - Vimarsana News

Self-Management Program for Chronic Migraine Does Not Improve Quality of Life

A brief group education and self-management program does not improve headache-related quality of life in patients with chronic migraine.

Headache-related quality of life lagged in adults with long COVID - Vimarsana News

Headache-related quality of life lagged in adults with long COVID

BOSTON — Headache-related quality of life lagged clinical improvement in headaches for individuals with long COVID at 12 to 19 months, according to a poster from the American Academy of Neurology annual meeting.“It helps to understand what the risks of long COVID are for patients who may previously suffer from headache in order to monitor and treat these patients in a way that is most

Source: healio.com